Drug Search Results
More Filters [+]

Glutamine

Alternative Names: glutamine, l-glutamine, endari, nutrestore
Latest Update: 2024-02-02
Latest Update Note: News Article

Product Description

Glutamine is the most abundant and versatile amino acid in the body. Glutamine is the most abundant and versatile amino acid in the body, and is of fundamental importance to intermediary metabolism, interorgan nitrogen exchange via ammonia (NH3) transport between tissues, and pH homeostasis. (Sourced from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6266414/)

Mechanisms of Action: GLS Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous

FDA Designation: Orphan Drug - *

Approval Status: Approved

Approved Countries: Argentina | Australia | Austria | Belgium | Brazil | Bulgaria | Chile | China | Colombia | Croatia | Czech | Ecuador | Egypt | Estonia | Finland | France | Greece | Hong Kong | Hungary | India | Indonesia | Ireland | Korea | Latvia | Lebanon | Lithuania | Malaysia | Netherlands | New Zealand | Pakistan | Peru | Philippines | Poland | Portugal | Romania | Saudi Arabia | Serbia | Singapore | Slovakia | Slovenia | Spain | Sweden | Switzerland | Taiwan | Thailand | Turkey | United Arab Emirates | United Kingdom | United States | Uruguay | Venezuela | Vietnam

Approved Indications: Anemia, Sickle Cell

Known Adverse Events: Abdominal Pain | Back Pain | Chest Pain | Headache | Pain Unspecified | Constipation

Company: Emmaus Medical
Company Location: TORRANCE CA 90503
Company CEO: Yutaka Niihara
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Glutamine

Countries in Clinic: United States

Active Clinical Trial Count: 2

Highest Development Phases

Phase 1: Adenocarcinoma|Colonic Diseases|Diverticulosis, Colonic|Pancreatic Cancer|Pancreatic Ductal Carcinoma

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

GlutaPanc

P1

Active, not recruiting

Pancreatic Ductal Carcinoma|Pancreatic Cancer|Adenocarcinoma

2023-07-06

EM-DsD-002

P1

Completed

Colonic Diseases|Diverticulosis, Colonic

2022-12-30

21%

Recent News Events